Opinions

Take the perspectives of key opinion leaders on some of the most debated topics in oncology which are changing clinical practice.

William Travis

Assessing pathological response after neoadjuvant treatment for NSCLC

Much progress has been made in the standardisation of pathological response but optimising viable tumour cutoffs for predicting long-term outcome after different treatment modalities and by histological type remain key areas for investigation 

By William Travis

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.